SOGECLAIR (ALSOG.PA) Stock Fundamental Analysis
EPA:ALSOG - Euronext Paris - Matif - FR0000065864 - Common Stock - Currency: EUR
ALSOG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 45 industry peers in the Aerospace & Defense industry. ALSOG has an average financial health and profitability rating. ALSOG scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make ALSOG a good candidate for value investing.
1. Profitability
1.1 Basic Checks
ALSOG had positive earnings in the past year.
In the past year ALSOG had a positive cash flow from operations.
ALSOG had positive earnings in 4 of the past 5 years.
Each year in the past 5 years ALSOG had a positive operating cash flow.
1.2 Ratios
ALSOG has a Return On Assets (2.90%) which is comparable to the rest of the industry.
The Return On Equity of ALSOG (9.03%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 7.14%, ALSOG is in line with its industry, outperforming 53.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ALSOG is below the industry average of 8.61%.
The last Return On Invested Capital (7.14%) for ALSOG is above the 3 year average (6.22%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 9.03% | ||
| ROIC | 7.14% |
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.82%, ALSOG is doing worse than 66.67% of the companies in the same industry.
ALSOG's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 4.65%, ALSOG is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of ALSOG has grown nicely.
ALSOG has a Gross Margin of 56.71%. This is amongst the best in the industry. ALSOG outperforms 84.44% of its industry peers.
In the last couple of years the Gross Margin of ALSOG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.65% | ||
| PM (TTM) | 2.82% | ||
| GM | 56.71% |
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ALSOG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ALSOG has about the same amount of shares outstanding.
The debt/assets ratio for ALSOG has been reduced compared to a year ago.
2.2 Solvency
ALSOG has an Altman-Z score of 2.40. This is not the best score and indicates that ALSOG is in the grey zone with still only limited risk for bankruptcy at the moment.
ALSOG has a Altman-Z score (2.40) which is comparable to the rest of the industry.
The Debt to FCF ratio of ALSOG is 1.82, which is an excellent value as it means it would take ALSOG, only 1.82 years of fcf income to pay off all of its debts.
ALSOG has a better Debt to FCF ratio (1.82) than 80.00% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that ALSOG is not too dependend on debt financing.
The Debt to Equity ratio of ALSOG (0.44) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 1.82 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.96
WACC7.41%
2.3 Liquidity
ALSOG has a Current Ratio of 1.69. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG has a better Current ratio (1.69) than 80.00% of its industry peers.
ALSOG has a Quick Ratio of 1.44. This is a normal value and indicates that ALSOG is financially healthy and should not expect problems in meeting its short term obligations.
ALSOG's Quick ratio of 1.44 is amongst the best of the industry. ALSOG outperforms 86.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
ALSOG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.56%, which is quite impressive.
Measured over the past years, ALSOG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.82% on average per year.
Looking at the last year, ALSOG shows a small growth in Revenue. The Revenue has grown by 6.07% in the last year.
Measured over the past years, ALSOG shows a quite strong growth in Revenue. The Revenue has been growing by 9.06% on average per year.
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%
3.2 Future
ALSOG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.42% yearly.
Based on estimates for the next years, ALSOG will show a small growth in Revenue. The Revenue will grow by 6.01% on average per year.
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 19.59, the valuation of ALSOG can be described as rather expensive.
Based on the Price/Earnings ratio, ALSOG is valued cheaply inside the industry as 95.56% of the companies are valued more expensively.
ALSOG is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.36, ALSOG is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALSOG indicates a rather cheap valuation: ALSOG is cheaper than 97.78% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. ALSOG is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.59 | ||
| Fwd PE | 12.36 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ALSOG is valued cheaply inside the industry as 97.78% of the companies are valued more expensively.
ALSOG's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALSOG is cheaper than 97.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.94 | ||
| EV/EBITDA | 9.09 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALSOG's earnings are expected to grow with 18.42% in the coming years.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y19.67%
EPS Next 3Y18.42%
5. Dividend
5.1 Amount
ALSOG has a Yearly Dividend Yield of 3.40%. Purely for dividend investing, there may be better candidates out there.
ALSOG's Dividend Yield is rather good when compared to the industry average which is at 1.20. ALSOG pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, ALSOG pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ALSOG pays out 64.84% of its income as dividend. This is not a sustainable payout ratio.
DP64.84%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPA:ALSOG (7/4/2025, 7:00:00 PM)
28.4
+0.2 (+0.71%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners4.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap90.88M
Analysts86.67
Price Target28.05 (-1.23%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
Yearly Dividend0.94
Dividend Growth(5Y)N/A
DP64.84%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.59 | ||
| Fwd PE | 12.36 | ||
| P/S | 0.58 | ||
| P/FCF | 5.94 | ||
| P/OCF | 5.33 | ||
| P/B | 1.86 | ||
| P/tB | 3.48 | ||
| EV/EBITDA | 9.09 |
EPS(TTM)1.45
EY5.11%
EPS(NY)2.3
Fwd EY8.09%
FCF(TTM)4.78
FCFY16.83%
OCF(TTM)5.32
OCFY18.75%
SpS49.07
BVpS15.31
TBVpS8.15
PEG (NY)0.73
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.9% | ||
| ROE | 9.03% | ||
| ROCE | 8.19% | ||
| ROIC | 7.14% | ||
| ROICexc | 9.23% | ||
| ROICexgc | 13.76% | ||
| OM | 4.65% | ||
| PM (TTM) | 2.82% | ||
| GM | 56.71% | ||
| FCFM | 9.74% |
ROA(3y)2.07%
ROA(5y)-0.15%
ROE(3y)6.51%
ROE(5y)-1.92%
ROIC(3y)6.22%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)10.8%
ROICexgc(5y)N/A
ROCE(3y)7.22%
ROCE(5y)N/A
ROICexcg growth 3Y2.87%
ROICexcg growth 5YN/A
ROICexc growth 3Y7.7%
ROICexc growth 5YN/A
OM growth 3Y10.77%
OM growth 5YN/A
PM growth 3Y8.83%
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score8
Asset Turnover1.03
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.44 | ||
| Debt/FCF | 1.82 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 51.95% | ||
| Cap/Sales | 1.11% | ||
| Interest Coverage | 7.47 | ||
| Cash Conversion | 160% | ||
| Profit Quality | 345.65% | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 2.4 |
F-Score8
WACC7.41%
ROIC/WACC0.96
Cap/Depr(3y)47.93%
Cap/Depr(5y)229.26%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.56%
EPS 3Y18.82%
EPS 5YN/A
EPS Q2Q%41.91%
EPS Next Y26.7%
EPS Next 2Y19.67%
EPS Next 3Y18.42%
EPS Next 5YN/A
Revenue 1Y (TTM)6.07%
Revenue growth 3Y9.06%
Revenue growth 5YN/A
Sales Q2Q%3.24%
Revenue Next Year7.59%
Revenue Next 2Y6.62%
Revenue Next 3Y6.01%
Revenue Next 5YN/A
EBIT growth 1Y3.84%
EBIT growth 3Y20.81%
EBIT growth 5YN/A
EBIT Next Year132.14%
EBIT Next 3Y38.24%
EBIT Next 5YN/A
FCF growth 1Y289.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y203.6%
OCF growth 3Y101.39%
OCF growth 5YN/A